百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONC 百济神州

盘前交易 06-01 07:24:52 EDT

287.92

-2.66

-0.92%

盘前290.00

+2.08+0.72%

07:00 EDT

最高294.30	最低287.53	成交量17.48万
今开293.30	昨收290.58	日振幅2.33%
总市值319.59亿	流通市值246.03亿	总股本1.11亿
成交额5,065万	换手率0.20%	流通股本8,545万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":287.92,"timestamp":1780084800000,"preClose":290.58,"halted":0,"volume":174817,"hourTrading":{"tag":"盘前","latestPrice":290,"preClose":287.92,"latestTime":"07:00 EDT","volume":1879,"amount":531273.60846,"timestamp":1780311600397,"change":2.08,"changeRate":0.007224,"amplitude":0.021221},"delay":0,"changeRate":-0.00915410558193946,"floatShares":85449100,"shares":111000000,"eps":4.404108,"marketStatus":"盘前交易","change":-2.66,"latestTime":"06-01 07:24:52 EDT","open":293.3,"high":294.3,"low":287.53,"amount":50646850.17401,"amplitude":0.023298,"askPrice":290,"askSize":7,"bidPrice":258.69,"bidSize":40,"shortable":3,"etf":0,"ttmEps":4.404108,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780320600000},"marketStatusCode":1,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":287.92,"preHourTrading":{"tag":"盘前","latestPrice":290,"preClose":287.92,"latestTime":"07:00 EDT","volume":1879,"amount":531273.60846,"timestamp":1780311600397,"change":2.08,"changeRate":0.007224,"amplitude":0.021221},"postHourTrading":{"tag":"盘后","latestPrice":287.92,"preClose":287.92,"latestTime":"18:26 EDT","volume":9156,"amount":2636196.32,"timestamp":1780093581758,"change":0,"changeRate":0,"amplitude":0.000069},"volumeRatio":0.7824527422044102,"impliedVol":0.3886,"impliedVolPercentile":0.088},"requestUrl":"/m/hq/s/ONC","defaultTab":"news","newsList":[{"id":"2639644366","title":"百济神州安泰适在华获批用于小细胞肺癌二线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2639644366","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639644366?lang=zh_cn&edition=full","pubTime":"2026-05-29 14:18","pubTimestamp":1780035480,"startTime":"0","endTime":"0","summary":"南方财经5月29日电，百济神州宣布，安泰适?（注射用塔拉妥单抗）获得国家药品监督管理局（NMPA）新增适应症批准，用于既往接受过1种系统性治疗（包括含铂化疗）失败的广泛期小细胞肺癌（ES-SCLC）成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605293754345695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK1500","LU1719994722.HKD","BK4526","ONC","LU0588546209.SGD","06160","LU1969619763.USD","LU1303224171.USD","BK4139","BK0239","LU0307460666.USD","BK1588","LU2328871848.SGD","BK1583","BK4588","688235","LU1251922891.USD","LU1770034418.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638196657","title":"本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨","url":"https://stock-news.laohu8.com/highlight/detail?id=2638196657","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638196657?lang=zh_cn&edition=full","pubTime":"2026-05-28 14:09","pubTimestamp":1779948540,"startTime":"0","endTime":"0","summary":"5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。　　100%创新药研发标的——港股通创新药ETF华宝午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。　　拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝标的指数区间跌幅已超过30%，当前位置或接近本轮调整底部区间，配置性价比凸显。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-05-28/doc-inhzmpqs0236306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","LU0348783233.USD","VXUS","LU0417516571.SGD","LU0348825331.USD","BK4588","BK4526","LU0540923850.HKD","LU1961090484.USD","BK1161","IE00BPRC5H50.USD","LU1969619763.USD","LU1720050803.USD","BK4139","LU1770034418.SGD","BK1588","LU0417516902.SGD","IE00B5MMRT66.SGD","06978","LU0561508036.HKD","LU2476274720.SGD","BK1574","BK4585","LU2399975544.HKD","159992","688235","IE00B543WZ88.USD","LU0307460666.USD","LU0348784397.USD","06160","520880","BK1500","LU0588546209.SGD","LU0348766576.USD","LU2476274308.USD","LU2778985437.USD","LU0348827113.USD","LU0348735423.USD","LU2328871848.SGD","LU0417516738.SGD","LU1794554557.SGD","09926","LU2488822045.USD","LU0348767384.USD","LU1303224171.USD","LU1719994722.HKD","LU1251922891.USD","ONC","LU0634319403.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2638630243","title":"上药控股与百济神州举行战略合作签约仪式","url":"https://stock-news.laohu8.com/highlight/detail?id=2638630243","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638630243?lang=zh_cn&edition=full","pubTime":"2026-05-28 08:32","pubTimestamp":1779928320,"startTime":"0","endTime":"0","summary":"人民财讯5月28日电，据上药控股消息，5月27日下午，上药控股与百济神州举行战略合作签约仪式，双方在医药健康领域的深度合作由此迈入全新发展阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283751977154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","ONC","BK4588","BK1161","LU2328871848.SGD","LU0588546209.SGD","LU1719994722.HKD","06160","LU1969619763.USD","LU0307460666.USD","688235","BK4139","BK4585","BK4526","BK1588","LU1251922891.USD","LU1303224171.USD","BK1500","BK0239","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638585985","title":"中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638585985?lang=zh_cn&edition=full","pubTime":"2026-05-25 13:59","pubTimestamp":1779688785,"startTime":"0","endTime":"0","summary":"参照恒指公司的行业分类，此次恒指调整后，对于医疗保健业的覆盖度从38.8%提升至44.3%，对于工业的覆盖度从54.3%提升至56.0%。该行根据此次恒生综合指数调整情况、结合港股通纳入的额外要求，预计6只或符合港股通纳入范围。此次进入恒生综合指数的Minimax-W由于其同股不同权性质，需额外满足上市满6个月及20个交易日的条件，因此不会在本次6月调整中进入港股通，预计于8月纳入港股通。若后续满足市值与成交额要求，有望于8月纳入港股通。","market":"sh","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7ab48a17674d5845193952fa54058c28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445467.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","BK1588","LU1770034418.SGD","BK1568","BK1589","02833","LU0540923850.HKD","83115","03416","LU0561508036.HKD","LU1720050803.USD","IE00B5MMRT66.SGD","07588","03037","BK1574","07288","LU0634319403.HKD","09067","BK1161","03088","LU0348783233.USD","LU0348766576.USD","LU1808992512.USD","LU0417516902.SGD","82828","LU0417516738.SGD","03417","HSCEI","09926","07226","LU1303224171.USD","02600","02828","BK1175","LU2399975544.HKD","HHImain","BK1500","03423","03067","09088","IE00BPRC5H50.USD","BK1191","LU1251922891.USD","LU2476274308.USD","MCHmain","03033","LU0348825331.USD","LU0588546209.SGD","01519","07300","82800","HSI","BK1583","LU1719994722.HKD","LU2328871848.SGD","LU2488822045.USD","02513","BK1513","LU0348827113.USD","513600","BK1117","HSTECH","02837","LU2778985437.USD","LU0348735423.USD","03032","03115","03419","LU1969619763.USD","07552","LU2476274720.SGD","HSCI","07200","ONC","BK1592","00100","LU1794554557.SGD","02800","601600","LU0417516571.SGD","LU1961090484.USD","IE00B543WZ88.USD","HK0000286598.CNH","LU0307460666.USD","09115","BK1151","06160","LU0348784397.USD","07500","LU0348767384.USD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637399348","title":"智谱、MiniMax，有望加入恒生科技指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2637399348","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637399348?lang=zh_cn&edition=full","pubTime":"2026-05-22 13:38","pubTimestamp":1779428280,"startTime":"0","endTime":"0","summary":"　　恒生指数公司将于今日收市后公布季度检讨结果。　　市场焦点集中在智谱、MiniMax这两只AI概念股，有望被纳入恒生科技指数及综合指数。　　根据市场分析，智谱、MiniMax因近期市值大幅上升，已成为纳入恒生科技指数的最有力候选。　　至于摩根士丹利此前预期，智谱、及MiniMax将于6月纳入恒生科技指数，合计权重约5%至7%，或带动12.5亿至17.5亿美元的被动资金流入，而纳入港股通可能会在6个月内将内地持股比例提升至自由流通股的9%至20%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-22/doc-inhytyys6180072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ONC","02423","09115","BK1233","LU0310800379.SGD","03423","LU0594300419.USD","02837","MHImain","LU0417516902.SGD","07200","07552","07500","LU1969619763.USD","01818","03067","LU2476274720.SGD","00100","02833","03088","03033","LU2476274308.USD","LU0634319403.HKD","LU0823426480.USD","BK1583","LU0228659784.USD","02800","07300","07226","LU2328871848.SGD","03037","LU2279701549.SGD","LU0588546209.SGD","LU0348766576.USD","LU0417516571.SGD","LU0708994859.HKD","LU0128525929.USD","HSTECH","LU0823426308.USD","688235","09067","LU1794554557.SGD","LU0348735423.USD","LU1251922891.USD","LU1303224171.USD","BK1574","03417","LU0348825331.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","03032","03115","BK1161","LU0417516738.SGD","LU2488822045.USD","09088","03419","IE0034224299.USD","82800","LU2399975544.HKD","YUMC","02513","IE00BPRC5H50.USD","BK1198","BEKE","LU0540923850.HKD","09926","LU1720050803.USD","MCHmain","LU0348783233.USD","BK1592","LU0348784397.USD","LU1719994722.HKD","LU0348827113.USD","LU1961090484.USD","513600","06160","BK1097","LU0029864427.USD","LU0650527681.SGD","BK1544","LU0307460666.USD","LU1267930573.SGD","BK1117","LU0348767384.USD","HHImain","BK1588","LU2778985437.USD","09987","BK1500","83115","LU1770034418.SGD","HSI","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636140728","title":"百济神州美股盘前涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636140728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636140728?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:12","pubTimestamp":1779264777,"startTime":"0","endTime":"0","summary":"百济神州美股盘前涨超10%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203743484856.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743484856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","BK1588","688235","BK1161","BK4526","BK4588","LU0307460666.USD","BK0239","BK4585","LU1251922891.USD","LU1303224171.USD","BK1583","LU1770034418.SGD","LU2328871848.SGD","LU1719994722.HKD","ONC","06160","LU1969619763.USD","LU0588546209.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636145813","title":"港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2636145813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636145813?lang=zh_cn&edition=full","pubTime":"2026-05-20 13:58","pubTimestamp":1779256684,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州涨近3%，截至发稿，涨2.23%，报178.7港元，成交额4.67亿港元。此前，百济神州披露26Q1业绩，中金指出，收入15.13亿美元，同比增长35%，其中产品收入14.87亿美元，同比增长34%，GAAP净利润2.27亿美元，同比增加2.26亿美元，销售收入符合该行预期，净利润超该行预期，主因费用控制较好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","LU0307460666.USD","ONC","BK4139","LU0588546209.SGD","BK1161","LU1719994722.HKD","BK1588","BK4588","BK0239","BK4526","LU1969619763.USD","LU1303224171.USD","LU1770034418.SGD","VXUS","LU2328871848.SGD","BK4585","06160","BK1500","BK1583","LU1251922891.USD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636885146?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","LU0588546209.SGD","BK1583","06160","BK4581","LU1303224171.USD","LU0516422366.SGD","BK1574","LU0708995583.HKD","BK1141","HK0000306701.USD","02269","SG9999014674.SGD","LU0417516902.SGD","01548","LU0823426308.USD","BK1161","BK1588","BK1589","LU0359201612.USD","XBI","LU0039217434.USD","LU1242518931.SGD","LU0043850808.USD","LU1719994722.HKD","LU3063872942.SGD","BK4588","09969","HK0000320264.USD","IE00B0JY6N72.USD","LU0456846285.SGD","LU0052750758.USD","161726","LU0348825331.USD","SG9999002562.SGD","LU0359202008.SGD","LU0181495838.USD","BK1576","LU0307460666.USD","LU0417516738.SGD","ONC","02268","06990","LU1251922891.USD","LU1688375341.USD","LU0320764599.SGD","LU0516422440.USD","LU1770034418.SGD","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883343","title":"大行集体看涨百济神州(06160)，\tQ1业绩印证长期投资价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883343","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636883343?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:10","pubTimestamp":1779153033,"startTime":"0","endTime":"0","summary":"GAAP口径下，百济神州Q1季度全球总收入达15.13亿美元，同比增长35.5%，超出此前FactSet一致预期的14.4亿美元。26Q1季度，百济神州产品收入达15亿美元，同比增长34%。该行在将百济神州维持“买入”评级的同时，将其美股目标价由430美元进一步上调至453美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","ONC","BK1583","LU1303224171.USD","LU0588546209.SGD","LU0307460666.USD","06160","BK4585","LU2328871848.SGD","LU1251922891.USD","LU1770034418.SGD","LU1719994722.HKD","BK0239","688235","BK4588","BK1500","BK4526","BK1161","LU1969619763.USD","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023442","title":"百济神州正在接近生命周期的一次切换","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023442","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636023442?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:13","pubTimestamp":1779092018,"startTime":"0","endTime":"0","summary":"文｜锦缎市场整体下跌时，百济神州再次成为资金流出的对象。BTK叙事的延伸一个常见的解读是，百济神州又增加了一款新药。从单品到矩阵的跃迁，本质上是公司生命周期的一次切换。索托克拉的获批，是百济神州在这条路径上迈出的一步。泽布替尼代表了百济神州的过去和现在。百济神州拿到了一张关键牌，但牌局远未到收官的阶段。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779076618818843533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1583","ONC","BK4588","BK1161","LU2328871848.SGD","LU0588546209.SGD","LU1719994722.HKD","06160","LU1969619763.USD","LU0307460666.USD","688235","BK4139","BK4585","BK4526","BK1588","LU1251922891.USD","LU1303224171.USD","BK1500","BK0239","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636702309","title":"美股中概股盘前涨跌互现，百度、阿里巴巴涨1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636702309","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636702309?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:02","pubTimestamp":1779091355,"startTime":"0","endTime":"0","summary":"5月18日，美股中概股盘前涨跌互现，百度、阿里巴巴涨1%，京东涨0.4%，拼多多持平，网易跌0.3%，百济神州跌0.8%，携程跌1%，理想汽车跌10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740446853.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740446853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BABU","LU2148611432.USD","LU0251143458.SGD","FLCH","LU1235294995.USD","LU1769817096.USD","BK4614","LU1051769294.HKD","BK4575","688235","LU0797268264.HKD","02015","LU0072462343.USD","BK4574","09618","BK4531","LU1152091168.USD","LU1046421795.USD","BK4543","BK4565","LU0651947912.USD","02843","BK4588","BK4558","DRAG","LU0072913022.USD","LU0738911758.USD","LU0651946864.USD","LU0979878070.USD","BK4607","LU1048588211.SGD","LU1823568750.SGD","06160","LU0359202008.SGD","BK4602","02823","LU0359201612.USD","BK4587","PDD","BK4502","YXI","BK4535","ALBmain","LU1267930227.SGD","BABO","LU1048596156.SGD","XPP","BK4581","BK4527","LU0348814723.USD","LU0106959298.USD","MCHI","BK4548","BBYY","LU0545039389.USD","LU1515016050.SGD","LU0310800965.SGD","LI","LU1115378108.SGD","LU0880133367.SGD","BK4122","LU1023057109.AUD","LU0918141887.USD","TCOM","KBAB","BK4538","LU1242518857.USD","LU0128525689.USD","LU1003077747.HKD","LU0501845795.SGD","IE00B0JY6N72.USD","BK4534","BABA","82823","LU1051768304.USD","LU0640798160.USD","BK4505","BK4533","BK4504","BABW","LU2226246903.HKD","ASHS","BIDG","LU0963586101.USD","FXP","KBDU","09988","JD","02822","LU0328353924.USD","LU0348816934.USD","82843","BK4612","CWEB","BK4550","BK4552","BK4077","09999","LU0553294199.USD","NTES","BK4220","LU1105468828.SGD","LU1152091754.HKD","LU1769817179.HKD","LU1242518931.SGD","09888","LU1688375341.USD","ONC","BK4514","LU0661504455.SGD","LU0949170772.SGD","LU1282648689.USD","BK4526","IE00BF5LJ272.USD","BK4503","LU0821914370.USD","LU1008478684.HKD","LU0173614495.USD","LU0918141705.HKD","LU1880383366.USD","09961","BK4554","LU0067412154.USD","BK4579","LU1046422090.SGD","BABX","IE00BFMHRM44.USD","82822","LU0287142896.SGD","LU0047713382.USD","BK4524","HXC","BIDU","LU0456842615.SGD","LU0052756011.USD","ASHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635936752","title":"百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2635936752","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635936752?lang=zh_cn&edition=full","pubTime":"2026-05-14 07:47","pubTimestamp":1778716032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，公司于2026年5月13日宣布百悦达获得美国食品药品监督管理局加速批准，用于治疗既往接受过至少两线系统治疗的复发或难治性(R/R)套细胞淋巴瘤成人患者。索托克拉是一款在BCL2靶点研发中具有基石性潜力的新一代BCL2抑制剂，其研发设计以增强BCL2抑制剂作用为目标，在分子效力和选择性方面进行了优化，且其药理学特性也有望改善用药的有效性、耐受性和便利性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU1719994722.HKD","06160","BK4588","LU1770034418.SGD","LU0307460666.USD","BK4526","688235","BK4139","BK0239","LU1303224171.USD","BK1500","BK1583","LU2328871848.SGD","LABU","LU1969619763.USD","LU0588546209.SGD","BK1588","LU1251922891.USD","BK4585","ONC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2635202523","title":"百济神州(06160)：授出受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202523","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202523?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:04","pubTimestamp":1778663056,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年5月8日，董事会薪酬委员会根据2016期权及激励计划的条款向201名承授人授出涉及合共25,436股美国存托股份的受限制股份单位。该等受限制股份单位相当于330,668股股份，约占本公告之日公司发行股份总数的0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","LU1303224171.USD","06160","LU2328871848.SGD","LU1719994722.HKD","LU1770034418.SGD","BK0239","LU0307460666.USD","BK4526","LU1251922891.USD","BK4588","ONC","688235","BK1588","BK1500","LU0588546209.SGD","LU1969619763.USD","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634228933","title":"百济神州一季度净利润超16亿元；今年医保谈判工作启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634228933","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634228933?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:04","pubTimestamp":1778501046,"startTime":"0","endTime":"0","summary":"政策动向今年医保谈判工作启动近日，国家医保局发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》，并向社会公开征求意见。21点评：根据《征求意见稿》，今年的工作程序仍分为准备、申报、评审、谈判、公布结果5个阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733316580.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733316580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","688235","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288993","title":"百济神州(06160)发布第一季度业绩 归母净利润16.08亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288993","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634288993?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:57","pubTimestamp":1778497043,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布2026年第一季度业绩，该集团取得营业收入105.44亿元，同比增长31.0%;归属于上市公司股东的净利润16.08亿元，同比扭亏为盈;基本每股收益1.11元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06160","688235","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633486147","title":"【券商聚焦】招银国际维持百济神州(ONC/06160)“买入”评级 指近期临床数据读出将验证创新管线价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2633486147","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633486147?lang=zh_cn&edition=full","pubTime":"2026-05-08 13:17","pubTimestamp":1778217451,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，百济神州 1Q26业绩强劲，盈利改善，管理层上调全年指引。此外，近期多项临床数据的读出将为公司估值的提升提供强有力的催化剂。此外，BTK CDAC的美国NDA预计将于下半年递交。实体瘤催化剂丰富： 在即将到来的ASCO年会上，公司将公布CDK4抑制剂、GPC3/4-1BB双抗及B7-H4 ADC的临床数据。CDK4抑制剂已经进入一线乳腺癌三期临床。GPC3/4-1BB双抗也已经进入后线肝癌注册临床阶段。维持“买入”评级，维持基于DCF模型的目标价392.43美元不变。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980931","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633107844","title":"中金：维持百济神州(06160)跑赢行业评级 目标价250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633107844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633107844?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:37","pubTimestamp":1778204248,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，综合考虑百济神州费用控制，维持2026年收入预测不变，上调盈利预测7.1%至6.5亿美元，并维持2027年盈利预测不变。该行维持跑赢行业评级，基于DCF模型，该行维持A/H/US股目标价320元/250港币/420美元。1Q26替雷利珠单抗全球销售额2.06亿美元，YoY +20%。GAAP净利润达到2.27亿美元，单季度盈利首次超过2亿美元，超过该行预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","EWH","ONC","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794147","title":"多家药企高管生变：恒瑞、复星、阿斯利康、辉瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633794147?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日，恒瑞医药发布公告，正式完成新一届董事会和管理层聘任。复星医药4月2日，复星医药发布首席财务官变更公告，因工作安排调整，陈战宇辞去首席财务官职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0985481810.HKD","01276","LU0122379950.USD","LU1883839398.USD","BK4533","LU1066051498.USD","SG9999001176.USD","ONC","LU0289739699.SGD","LU2237443895.HKD","SG9999002232.USD","LU0234572021.USD","LU0321505439.SGD","BK4588","LU2237443549.SGD","688235","IE00B19Z3581.USD","LU0058720904.USD","LU1023059063.AUD","LU2237443382.USD","BK4007","BK4534","LU1057294990.SGD","LU2237443622.USD","06160","LU2236285917.USD","LU1066053197.SGD","IE00BLSP4239.USD","LU0225284248.USD","PFE","LU0225771236.USD","AZN","SG9999003800.SGD","LU1894683264.USD","LU0456855351.SGD","BK4599","LU2456880835.USD","LU0868494617.USD","LU2417539215.USD","BK4581","02142","BK4592","BK4568","AZNH","IE00B3T34201.USD","BK4550","600276","02196","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0321505868.SGD","LU0170899867.USD","SG9999001176.SGD","LU0320765992.SGD","LU2237443465.HKD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0306806265.USD","SG9999013999.USD","LU2462157665.USD","SGXZ57979304.SGD","LU1829250122.USD","SG9999011175.SGD","600196","LU0109394709.USD","BK4585","LU0889565916.HKD","IE0002270589.USD","SG9999002224.SGD","LU0306807586.USD","LU1894683348.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633416218","title":"港股异动 | 百济神州(06160)绩后高开逾4% 一季度净利同比增长178.02倍 百悦泽全球销售额11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633416218","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633416218?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:25","pubTimestamp":1778117150,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州绩后高开逾4%，截至发稿，涨4.07%，报189.4港元，成交额4130.72万港元。消息面上，5月6日，百济神州公布2026年第一季度业绩，全球总收入达约15.13亿美元，同比增长35%。经调整经营利润约4.14亿美元，同比增长197%；经调整净利润约3.75亿美元，同比增长175%；净利润约2.27亿美元，同比增长178.02倍；自由现金流约1.61亿美元，同比增长14.03倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0307460666.USD","BK1161","BK4588","BK4526","LU1303224171.USD","06160","VXUS","LU2328871848.SGD","LU1719994722.HKD","BK4139","BK4585","LU0588546209.SGD","BK1500","BK1583","688235","BK0239","LU1969619763.USD","LU1770034418.SGD","BK1588","LU1251922891.USD","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633162625","title":"港股开盘强势 恒指高开1.21% 快手-W(01024)涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633162625","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633162625?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:24","pubTimestamp":1778117045,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美伊将达成结束战争协议，刺激大市气氛向上，隔晚美股强势带动港股情绪，恒指高开1.21%，国企指数高开1.3%，恒生科技指数高开2.41%。期内，经调整净利润3.75亿美元，按年增加175%。东方证券高开1.87%，公司宣布，向卖方收购上海证券合计100%股权。该公司已向上海证交所申请A股5月7日复牌。内地股市假后复市，大市走势向好，沪综指高开高走，收市上升1.2%，沪深两市成交额超过三万亿元水平。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fbe774582fff1943fbc8392a6b2fba8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980764","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999004220.SGD","03958","BK1147","SG9999001093.SGD","LU1251922891.USD","LU0307460666.USD","600958","000333","BK1528","LU0326950275.SGD","LU0611395673.USD","BK1226","LU0405327494.USD","01378","LU1522347837.USD","LU0348735423.USD","LU2097828474.EUR","LU1303224171.USD","LU0456827905.SGD","LU0572944931.SGD","688235","01024","LU0072462343.USD","LU0890818403.SGD","LU0293314216.USD","00883","LU0320764599.SGD","LU1328277881.USD","BK4588","LU0348805143.USD","LU0593848301.USD","SG9999003461.SGD","LU1224444064.USD","LU1048588211.SGD","CJEWY","06160","LU1634259391.SGD","LU1969619763.USD","LU0348766576.USD","00300","LU1770034418.SGD","BK1564","LU0359202008.SGD","LU2328871848.SGD","LU0359201612.USD","CSUAY","LU0051755006.USD","LU1282651121.HKD","LU0211977185.USD","LU1497733557.USD","603993","00857","XYIGY","LU0348784397.USD","LU0359201885.HKD","IE00B19Z5X02.USD","LU1282651048.USD","BK1575","LU0244354667.USD","BK1521","LU1794554557.SGD","LU0210526637.USD","LU1115378108.SGD","LU1023057109.AUD","02833","600938","LU1785774172.SGD","LU1831875114.USD","TCOM","HSTECH","LU0348825331.USD","LU0540923850.HKD","LU0862451753.SGD","LU0327786744.USD","LU0348783233.USD","LU0405327148.USD","BABA","SGXZ62798434.SGD","601857","SG9999014674.SGD","HHImain","IE00BWDBJ730.SGD","LU0463099449.HKD","03993","LU0640798160.USD","BK1095","LU1634259557.SGD","SGXZ86797644.SGD","LU1497734951.SGD","601088","01929","LU0348827113.USD","LU2293587155.HKD","LU0348783662.USD","01088","BK1590","IE00BQJZWZ67.USD","09988","81024","LU2097828714.EUR","BK1591","BK1610","LU2097828805.USD","LU0588546209.SGD","LU0675040207.SGD","BK1615","LU1808992512.USD","00868","09888","LU0348767384.USD","LU1961090484.USD","513600","MCHmain","ONC","LU2097828557.USD","LU0862451837.USD","LU0417516738.SGD","LU0417516571.SGD","LU0052750758.USD","LU0634319403.HKD","SG9999006597.SGD","LU1188198961.HKD","LU0561508036.HKD","LU0140636845.USD","LU2399975544.HKD","LU0173614495.USD","LU0314109678.HKD","09961","LU0441854154.USD","LU0469268626.HKD","BK1608","LU0972618739.USD","LU1719994722.HKD","HSI","LU1720050803.USD","LU2097828631.EUR","LU0287142896.SGD","LU1497733631.SGD","LU0181495838.USD","BIDU","LU0417516902.SGD","LU0708995583.HKD","LU1813983027.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.072},{"period":"1month","weight":-0.0099},{"period":"3month","weight":-0.0917},{"period":"6month","weight":-0.1547},{"period":"1year","weight":0.1672},{"period":"ytd","weight":-0.0523}],"compareEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.107},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.1093}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"　　百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.083709},{"month":2,"riseRate":0.6,"avgChangeRate":0.027535},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.02929},{"month":4,"riseRate":0.363636,"avgChangeRate":0.018832},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.019621},{"month":6,"riseRate":0.5,"avgChangeRate":0.012468},{"month":7,"riseRate":0.8,"avgChangeRate":0.147208},{"month":8,"riseRate":0.6,"avgChangeRate":0.034201},{"month":9,"riseRate":0.6,"avgChangeRate":0.069537},{"month":10,"riseRate":0.5,"avgChangeRate":-0.004517},{"month":11,"riseRate":0.6,"avgChangeRate":0.063715},{"month":12,"riseRate":0.3,"avgChangeRate":-0.043663}],"exchange":"NASDAQ","name":"百济神州","nameEN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,ONC,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}